Skip to main content
Wolfson Institute of Population Health
  1. WIPH
  2. People
  3. Profiles

Professor Peter MacCallum

Peter

Professor in Haematology

Email: p.k.maccallum@qmul.ac.uk
Telephone: +44 (0) 20 7882 6203

Profile

I am a clinical academic at the Wolfson Institute of Population Health, Queen Mary University of London, and an honorary consultant haematologist at Barts Health NHS Trust where I lead the clinical and laboratory thrombosis service at St Bartholomew’s and the Royal London Hospitals.

My research interests cover the field of venous thromboembolism (VTE) and mirror my clinical practice.

Much clinical and research time since March 2020 has been taken up with firstly the thrombotic complications of COVID-19 and subsequently the diagnosis and management of vaccine-induced thrombosis with thrombocytopenia.

Over the past 5 years I have been Chief Investigator of the ORANGE study, a prospective UK-based registry of outcomes of major bleeding on oral anticoagulants and the largest such study globally, and National Co-ordinating Investigator for GARFIELD-VTE, a prospective global registry that studied the management and outcomes of >10,000 patients with a new episode of VTE from >30 countries and to which the UK was the largest contributor (>900 patients).

Future plans include a collaboration to better understand the pathways of coagulation activation in patients with cancer, who contribute 10-20% of the population burden of VTE and for whom thrombosis is a leading cause of death.

I have additionally authored chapters on thrombosis in major UK textbooks including the Oxford Textbook of Medicine, Kumar and Clark’s Clinical Medicine, and Postgraduate Haematology. 

I regularly teach medical students in PBLs and tutorials and some of my students have gone on to present findings from their specialist study modules at national and international conferences. I also act as student mentor. Despite the problems resulting from the COVID-19 pandemic my current MD(Res) student passed her viva within 4 years.

Research

Research Interests:

Thrombosis – epidemiology; pathogenesis of cancer-associated thrombosis; diagnosis, prevention and management of venous thromboembolism; personalised medicine approach to VTE management

 

Publications

Green L, Tan J, Morris JK, Alikhan R, Curry N, Everington T, Maclean R, Saja K, Stanworth S, Tait C, MacCallum P. A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study). Haematologica 2018;103:738-45. doi: 10.3324/haematol.2017.182220.

Young AM, Marshall A, Thirlwall J, Chapman O, Lokare A, Hill C, Hale D, Dunn JA, Lyman GH, Hutchinson C, MacCallum P, Kakkar A, Hobbs R, Petrou S, Dale J, Poole CJ, Levine M. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in cancer patients with venous thromboembolism: results of a randomized trial (SELECT-D). J Clin Oncol 2018;36:2017-23. doi: 10.1200/JCO.2018.78.8034. 

Bowles L, Platton S, Yartey N, Dave M, Lee K, Hart DP, MacDonald V, Green L, Sivapalaratnam S, Pasi KJ, MacCallum P. Lupus anticoagulant and abnormal coagulation tests in patients with Covid-19. New Engl J Med 2020;383:288-90. DOI: 10.1056/NEJMc2013656

  • Prandoni P, Haas S, Fluharty M et al. (2024). Incidence and risk factors of post-thrombotic syndrome in patients with isolated calf vein thrombosis. Findings from the GARFIELD-VTE registry. nameOfConference


    QMRO: qmroHref
  • Barco S, Virdone S, Götschi A et al. (2023). Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials. nameOfConference


  • Kohli R, Platton S, Forbes S et al. (2023). Renal transplant and hemostasis: early postoperative changes in recipients and donors. nameOfConference


    QMRO: qmroHref
  • Platton S, Hill C, Lester W et al. (2023). Effect of argatroban on laboratory measurement of fibrinogen activity in ex vivo samples – Potential for errors in clinical decision‐making. nameOfConference


    QMRO: qmroHref
  • Turpie AGG, Farjat AE, Haas S et al. (2023). 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE. nameOfConference


  • Haas S, Farjat AE, Pieper K et al. (2022). On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease. nameOfConference


    QMRO: qmroHref
  • Kohli R, Allen E, Platton S et al. (2022). Effect on haemostasis of different replacement fluids during therapeutic plasma exchange—A comparative multicentre observational study. nameOfConference


    QMRO: qmroHref
  • Cools F, Virdone S, Sawhney J et al. (2022). Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial. nameOfConference


  • Kohli R, Geneen LJ, Brunskill SJ et al. (2022). Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic scoping review of outcome measures used. nameOfConference


  • Arachchillage DJ, Mackillop L, Chandratheva A et al. (2022). Thrombophilia testing: A British Society for Haematology guideline. nameOfConference


    QMRO: qmroHref
  • Gardiner C, Mackie IJ, MacCallum P et al. (2022). Automated measurement of coagulation and fibrinolytic activation markers: Outcomes in coronavirus disease 2019 (COVID‐19) patients. nameOfConference


  • Higgins H, Andrews N, Stowe J et al. (2022). Risk of thrombosis with thrombocytopenia syndrome after COVID‐19 vaccination prior to the recognition of vaccine‐induced thrombocytopenia and thrombosis: A self‐controlled case series study in England. nameOfConference


  • Cohen AT, Lewis M, Connor A et al. (2022). Thirty‐day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life‐threatening direct oral anticoagulant‐related bleeding. nameOfConference


    QMRO: qmroHref
  • Entwistle NMA, Ricketts W, Thedoulou A et al. (2022). Postdischarge complications and mortality of hospitalised patients with COVID-19 in East London Hospitals. nameOfConference

    DOI: doi

  • Platton S, Schönborn L, Charrot S et al. (2022). Vaccine‐induced immune thrombocytopenia and thrombosis: The decline in anti‐platelet factor 4 antibodies is assay‐dependent. nameOfConference


  • Cohen O, Ageno W, Farjat AE et al. (2022). Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD‐VTE. nameOfConference


    QMRO: qmroHref
  • Weitz JI, Farjat AE, Ageno W et al. (2021). Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD‐VTE. nameOfConference


  • Platton S, Bartlett A, MacCallum P et al. (2021). Evaluation of laboratory assays for anti‐platelet factor 4 antibodies after ChAdOx1 nCOV‐19 vaccination. nameOfConference


  • Goto S, Turpie AGG, Farjat AE et al. (2021). The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE. nameOfConference


  • Jerjes-Sánchez C, Rodriguez D, Farjat AE et al. (2021). Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE. nameOfConference


  • Makariou N, Mills S, Bariana T et al. (2021). Virtual clinics - the future of thrombosis and anticoagulant consultations? A patient preference survey.. nameOfConference

    DOI: doi

  • Tan J, Maccallum P, Curry N et al. (publicationYear). Correction of International Normalised Ratio in major bleeding related to vitamin K antagonists is associated with better survival: a UK study. nameOfConference


  • Bowles L, Platton S, Yartey N et al. (2020). Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.. nameOfConference


  • Weitz JI, Haas S, Ageno W et al. (2020). Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE. nameOfConference


    QMRO: qmroHref
  • Kohli R, Estcourt L, Zaidi A et al. (2020). Efficacy and safety of chemical thromboprophylaxis in renal transplantation – A systematic review. nameOfConference


  • Cohen AT, Lewis M, Connor A et al. (2020). 30 DAY MORTALITY FOLLOWING ANDEXANET ALFA IN ANNEXA-4 COMPARED WITH PROTHROMBIN COMPLEX CONCENTRATE (PCC) THERAPY IN THE ORANGE STUDY FOR LIFE THREATENING NON-VITAMIN K ORAL ANTICOAGULANT (NOAC) RELATED BLEEDING. nameOfConference


    QMRO: qmroHref
  • Kohli R, Estcourt L, Zaidi A et al. (2020). A systematic review of efficacy and safety of chemical thromboprophylaxis in renal transplantation. nameOfConference

    DOI: doi

  • Mehta D, Jones DM, Guha A et al. (2020). DOACs for stroke prevention in patients with AF and cancer.. nameOfConference


    QMRO: qmroHref
  • Haywood M, Bowles L, Platton S et al. (2020). Heparin-induced thrombocytopaenia (HIT): an audit of the diagnostic pathway at Barts Health NHS Trust. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Poynton M, Hibbs S, MacCallum P et al. (2020). Incidence and management of PEGylated-asparaginase related thrombosis in adults with ALL. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Todd S, Sivapathasuntharam D, Bowles L et al. (2020). Management of traumatic intracranial haemorrhage in elderly patients on anticoagulation: a trauma centre experience. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • MacCallum PK, Bowles L (2020). Thrombosis in pregnancy. nameOfConference


    QMRO: qmroHref
  • Chahal JK, Antoniou S, Earley M et al. (2019). Preventing strokes in people with atrial fibrillation by improving ABC.. nameOfConference


  • Green L, Tan J, Antoniou S et al. (2019). Haematological management of major bleeding associated with direct oral anticoagulants – UK experience. nameOfConference


  • Kohli R, Forbes S, Thuraisingham R et al. (2019). Survey of thromboprophylaxis strategies in renal transplant recipients at a single transplant unit. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Carroll R, Mansell J, Platton S et al. (2018). The Future of Activated Clotting Time?. nameOfConference


  • MacCallum PK, Thomson JM, Poller L (1990). Effects of Fixed Minidose Warfarin on Coagulation and Fibrinolysis Following Major Gynaecological Surgery. nameOfConference


    QMRO: qmroHref
  • Young AM, Marshall A, Thirlwall J et al. (2018). Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).. nameOfConference


  • Green L, Tan J, Morris JK et al. (2018). A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK (ORANGE study). nameOfConference


  • Wedzicha JA, Seemungal TA, MacCallum PK et al. (2000). Acute Exacerbations of Chronic Obstructive Pulmonary Disease Are Accompanied by Elevations of Plasma Fibrinogen and Serum IL-6 Levels. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Cooper JA, Martin J et al. (2000). Haemostatic and Lipid Determinants of Prothrombin Fragment F1.2 and D-dimer in Plasma. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Cooper JA, Howarth DJ et al. (1998). Sex Differences in the Determinants of Fibrinolytic Activity. nameOfConference


    QMRO: qmroHref
  • Green L, Tan J, Grist C et al. (2017). Aetiology and outcome of massive transfusion in two large London teaching hospitals over a 3-year period (2012–2014). nameOfConference


  • Collins J, Bowles L, MacCallum PK (2016). Prevention and management of venous thromboembolism in pregnancy. nameOfConference


    QMRO: qmroHref
  • MacCallum P (2001). Book Review. nameOfConference


    QMRO: qmroHref
  • Platton S, Bowles L, MacCallum P (2017). Effects of rivaroxaban on routine coagulation screening tests using commonly used reagents. nameOfConference


  • Poller L, Thomson JM, MacCallum PK et al. (1995). Minidose Warfarin and Failure to Prevent Deep Vein Thrombosis After Joint Replacement Surgery Despite Inhibiting the Postoperative Rise in Plasminogen Activator Inhibitor Activity. nameOfConference


    QMRO: qmroHref
  • Benbow EW, Love EM, Love HG et al. (1987). Massive Right Atrial Thrombus Associated with a Chiari Network and a Hickman Catheter. nameOfConference


    QMRO: qmroHref
  • (2016). Antiphospholipid syndrome: pathophysiology, diagnosis and treatment. nameOfConference


    QMRO: qmroHref
  • Collins J, Greinacher A, MacCallum P (2016). Autoimmune heparin-induced thrombocytopenia: A case report. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Platton SJM, Bowles L, MacCallum PK (2016). Dilute Russell's viper venom time - potential use for the detection of apixaban and rivaroxaban predicted from interference in lupus anticoagulant testing. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Platton SJM, Bowles L, MacCallum PK (2016). Effects of rivaroxaban and apixaban on routine coagulation screening tests. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Tait CR, Morris JK, Tan J et al. (2016). Trends in oral anticoagulant prescriptions and major bleeding complications: A comparison of NHS CCG prescription data with cases from a prospective study (ORANGE) between October 2013 and June 2015. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Renukanthan A, Quinton R, Turner B et al. (2015). Kallmann syndrome patient with gender dysphoria, multiple sclerosis, and thrombophilia. nameOfConference


    QMRO: qmroHref
  • Kalkur P, Kreze O, Chauhan N et al. (2015). Direct oral anti-coagulants for prevention of stroke and systemic embolism in non-valvular atrial fibrillation - Barts Health experience across two sites. nameOfConference

    DOI: doi

  • Green L, Morris J, Alikhan R et al. (2015). Oral anticoagulant agent-associated bleeding events reporting system (ORANGE) study. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Frise CJ, MacCallum PK, Mackillop LH et al. (2015). Systemic Thromboembolism in Pregnancy: Thromboprophylaxis. nameOfConference


    QMRO: qmroHref
  • Badle S, Coppack S, MacCallum P (2015). Thromboprophylaxis in a patient with morbid obesity. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Green L, Alikhan R, Curry N et al. (2014). Oral anticoagulant agent-associated bleeding events reporting system (ORANGE) study.. nameOfConference


    QMRO: qmroHref
  • MacCallum P, Bowles L, Keeling D (2014). Diagnosis and management of heritable thrombophilias.. nameOfConference


    QMRO: qmroHref
  • Dadgar M, Pickford G, MacCallum P et al. (2014). PWE-080 Beware The Interaction Between Thiopurines And Warfarin. nameOfConference


    QMRO: qmroHref
  • Robson J, Dostal I, Mathur R et al. (2014). Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts.. nameOfConference


    QMRO: qmroHref
  • Rahiminejad M, Rastogi A, Prabhudesai S et al. (2014). Evaluating the Use of a Negative D-Dimer and Modified Low Wells Score in Excluding above Knee Deep Venous Thrombosis in an Outpatient Population, Assessing Need for Diagnostic Ultrasound.. nameOfConference


    QMRO: qmroHref
  • Sinha S, Hossain U, MacCallum P (2014). SCREENING FOR MALIGNANCY IN PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Maccallum PK, Mathur R, Hull SA et al. (2013). Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study.. nameOfConference


  • MacCallum PK, Mathur R, Hull SA et al. (2013). Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation. nameOfConference


  • Van der Krogt L, Barber C, MacCallum P et al. (2013). Retrospective study of the Massive Haemorrhage Protocol adherence in the management of trauma-induced bleeding at the Royal London Hospital. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • MacCallum PK (2013). COPD and thrombosis. nameOfConference


    QMRO: qmroHref
  • Raza I, Davenport R, Rourke C et al. (2013). The incidence and magnitude of fibrinolytic activation in trauma patients.. nameOfConference


    QMRO: qmroHref
  • Mpouzouki A, Bowles L, Beski S et al. (2013). A retrospective review of risk factors for thrombosis in women presenting with venous thromboembolism (VTE) during pregnancy and the puerperium. nameOfConference


    QMRO: qmroHref
  • Platton SJ, Nahar B, Dale C et al. (2013). False-positive results for a lupus anticoagulants occur in patients on low molecular weight heparin but not fondaparinux, by dilute activated partial thromboplastin time. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Frise CJ, MacCallum PK, Mackillop LH et al. (2012). Systemic Thromboembolism in Pregnancy: Thromboprophylaxis. nameOfConference


    QMRO: qmroHref
  • Verghese L, Alam S, Beski S et al. (2012). Antenatal screening for pre-eclampsia: evaluation of the NICE and pre-eclampsia community guidelines.. nameOfConference


    QMRO: qmroHref
  • Kint M, Platton S, Hart D et al. (2012). A retrospective study of thrombophilia testing requests in a large teaching hospital. nameOfConference


    QMRO: qmroHref
  • Pandya J, Islam A, MacCallum P et al. (2012). A single-centre retrospective study of prothrombin complex concentrate (octaplex) use. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Provan D, Newland AC, MacCallum PK (2011). Acquired disorders affecting megakaryocytes and platelets. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Ashby D, Hennessy EM et al. (2011). Cumulative flying time and risk of venous thromboembolism.. nameOfConference


    QMRO: qmroHref
  • Davenport R, Manson J, De'Ath H et al. (2011). Functional definition and characterization of acute traumatic coagulopathy.. nameOfConference


    QMRO: qmroHref
  • Agarwal N, Deinde O, Willmott F et al. (2011). A case series of interventional radiology in postpartum haemorrhage.. nameOfConference


    QMRO: qmroHref
  • Provan D, Newland AC, MacCallum PK (2011). Acquired disorders affecting megakaryocytes and platelets. nameOfConference


    QMRO: qmroHref
  • Davenport R, Manson J, De'Ath H et al. (2011). Point of care diagnostics for the rapid identification of acute traumatic coagulopathy and prediction of massive trauma haemorrhage. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Prabhudesai SG, Rastogi A, Platton S et al. (2011). Evaluating the use of negative D-Dimer and low wells score in excluding above knee deep venous thrombosis in an outpatient population at a major London teaching hospital. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Varma G, Mills S, Gutteridge C et al. (2011). Implementation of a venous thromboembolism (VTE) risk assessment tool to improve inpatient thromboprophylaxis. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Raza I, Davenport R, Rourke C et al. (2011). Occult activation of fibrinolysis in trauma. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Uprichard J, Boomla K, Mills S et al. (2011). The incidence of venous thromboembolism (VTE) in East London. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Uprichard J, Mills S, MacCallum PK et al. (2011). The use of an electronic patient record to improve patient safety for anticoagulation. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Posner C, Owen M, Melhem N et al. (2010). An acutely swollen leg. nameOfConference


    QMRO: qmroHref
  • Rao AP, Bojahr H, Beski S et al. (2010). Role of interventional radiology in the management of morbidly adherent placenta. nameOfConference


    QMRO: qmroHref
  • Rudnicka AR, MacCallum PK, Whitelocke R et al. (2010). Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study.. nameOfConference


    QMRO: qmroHref
  • Coleman R, MacCallum P (2010). Treatment and secondary prevention of venous thromboembolism in cancer. nameOfConference


    QMRO: qmroHref
  • Saha A, Nguyen T, Watson C et al. (2010). The implementation of a simple step-wise intervention which dramatically improved the thromboprophylaxis rate in medical cancer patients. nameOfConference


    QMRO: qmroHref
  • Macey MG, Bevan S, Alam S et al. (2010). Platelet activation and endogenous thrombin potential in pre-eclampsia.. nameOfConference


    QMRO: qmroHref
  • Tillotson GS (2009). Introduction: Medical Education. nameOfConference


    QMRO: qmroHref
  • Meade TW, MacCallum PK (2005). Coagulation, thrombosis, and coronary heart disease. nameOfConference


    QMRO: qmroHref
  • Truss NJ, Beavis J, Maccallum PK et al. (2009). Rapid and accurate method for the von Willebrand factor ristocetin cofactor assay using 96-well microtiter plates. nameOfConference


    QMRO: qmroHref
  • Poller L, Keown M, Ibrahim S et al. (2009). A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Mt-Isa S, Whyte K et al. (2009). Air travel and risk of venous thromboembolism: a community-based study. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Hogg M, MacCallum P, Beski S (2009). Angiomyolipoma with renal vein thrombosis in pregnancy: a case report and review of the literature. nameOfConference


    QMRO: qmroHref
  • Rudnicka AR, MacCallum PK, Whitelocke R et al. (2009). Circulating markers of arterial thrombosis and age-related maculopathy: a case-control study. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Hossain SR, Madhani M, Varma G et al. (2009). Measures to improve safety of warfarinized patients following hospital discharge. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Greaves P, Madhani M, Hallam S et al. (2009). Off-license use of recombinant factor VIIa: a single centre experience. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Davenport R, Coates A, Allard S et al. (2009). TRAUMA HAEMORRHAGE: EVOLVING ROLE OF ROTEM FOR PREDICTING TRANSFUSION REQUIREMENTS. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Poller L, Keown M, Ibrahim S et al. (2008). An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. nameOfConference


    QMRO: qmroHref
  • Madhani M, Pasi KJ, Gutteridge CN et al. (2008). Preventing venous thromboembolism (VTE) in hospitalised patients: putting guidance into practice. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • MacCallum P, Madhani M, Mt-Isa S et al. (2007). Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin.. nameOfConference


    QMRO: qmroHref
  • Slater SE, Maccallum PK, Birjandi F et al. (1992). Acute myelogenous leukemia (AML) and diabetes insipidus (DI): Further association with monosomy 7. nameOfConference


    QMRO: qmroHref
  • Whelan JS, Davis CL, Rohatiner AZS et al. (1992). Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancy. nameOfConference


    QMRO: qmroHref
  • Banerjee P, Maccallum PK, Walker RWH et al. (1995). Polyradiculopathy complicating acute lymphoblastic leukemia. nameOfConference


    QMRO: qmroHref
  • Coats TJ, Brazil E, Heron M et al. (2006). Impairment of coagulation by commonly used resuscitation fluids in human volunteers. nameOfConference


    QMRO: qmroHref
  • Akinwunmi F, Engova D, Duggan C et al. (2006). Patient satisfaction as an anticoagulation service development tool. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • MacCallum PK, Hennessey EM, Beski S (2006). Incidence of pregnancy-associated venous thromboembolism.. nameOfConference


    QMRO: qmroHref
  • Donaldson GC, Seemungal TA, Patel IS et al. (2006). Airway and systemic inflammation and decline in lung function in patients with COPD Chest 2005;128:1995–2004. nameOfConference


    QMRO: qmroHref
  • Gauthaman N, Holden E, Mandana R et al. (2006). Clinical outcome of high risk patients on enoxaparin during the antenatal period - a prospective study.. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • MACCALLUM PK, Madhani M (2006). Managing VTE. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Donaldson GC, Seemungal TAR, Patel IS et al. (2005). Airway and systemic inflammation and decline in lung function in patients with COPD.. nameOfConference


    QMRO: qmroHref
  • MacCallum PK (2005). Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers.. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Rudnicka AR, Rumley A et al. (2004). Low-intensity warfarin reduces thrombin generation and fibrin turnover, but not low-grade inflammation, in men at risk of myocardial infarction. nameOfConference


    QMRO: qmroHref
  • Engova D, Duggan C, MacCallum P (2004). The role of medication adherence in warfarin anticoagulation control and its cognitive determinants. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • MacCallum PK, Cooper JA, Rumley A et al. (2004). Effect of bezafibrate on plasma homocysteine concentration in men with lower extremity arterial disease.. nameOfConference


    QMRO: qmroHref
  • Hill AS, MacCallum PK, Young BD et al. (2003). Molecular cloning of a constitutional t(7;22) translocation associated with risk of hematological malignancy.. nameOfConference


    QMRO: qmroHref
  • Bowles LK, Cooper JA, Howarth DJ et al. (2003). Associations of haemostatic variables with body mass index: a community-based study.. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Rudnicka AR, Rumley A et al. (2003). Low-intensity warfarin reduces thrombin generation and fibrin turnover without affecting inflammation. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Kennon S, Price CP, Mills PG et al. (2003). Cumulative risk assessment in unstable angina: clinical, electrocardiographic, autonomic, and biochemical markers.. nameOfConference


    QMRO: qmroHref
  • MACCALLUM PK, Miller GJ, Meade TW (2003). The haemostatic system in arterial disease.. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Seemungal TAR, Wedzicha JA, MacCallum PK et al. (2002). Chlamydia pneumoniae and COPD exacerbation.. nameOfConference


    QMRO: qmroHref
  • Engova D, Duggan C, Shearer M et al. (2002). Effects of age and cytochrome P450 polymorphism on the maintenance dose of warfarin.. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Jamshidi Y, Flavell DM, Hawe E et al. (2002). Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.. nameOfConference


    QMRO: qmroHref
  • Gale CR, Ashurst HE, Hall NF et al. (2002). Size at birth and carotid atherosclerosis in later life. nameOfConference


    QMRO: qmroHref
  • MACCALLUM PK (2002). Anticoagulant therapy following oral anticoagulant treatment for VTE.. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Maccallum, Cooper, Martin et al. (1998). Associations of protein C and protein S with serum lipid concentrations. nameOfConference


    QMRO: qmroHref
  • Seemungal T, Harper-Owen R, Bhowmik A et al. (2001). Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Brennan PJ, Meade TW (2001). Minimum intensity anticoagulation therapy as primary prevention strategy - In reply. nameOfConference


    QMRO: qmroHref
  • Rohatiner AZS, LISTER TA, Dalley CD et al. (2001). Acute myelogenous leukaemia in patients 60 years and older, a retrospective analysis from St. Bartholomew's Hospital 1969-1999.. nameOfConference


    QMRO: qmroHref
  • MACCALLUM PK, Cavenagh J, Thomas JM et al. (2001). Optimising testing for phospholipid antibodies.. nameOfConference


    QMRO: qmroHref
  • MACCALLUM PK, Barlow C, Edwards MJ et al. (2001). Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma.. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Brennan PJ, Meade TW (2000). Minimum Effective Intensity of Oral Anticoagulant Therapy in Primary Prevention of Coronary Heart Disease. nameOfConference


    QMRO: qmroHref
  • Kennon S, Barakat K, Suliman A et al. (2000). Influence of previous aspirin treatment and smoking on the electrocardiographic manifestations of injury in acute myocardial infarction. nameOfConference


    QMRO: qmroHref
  • Roland MA, Seemungal TAR, Bhowmik A et al. (1999). P17 Effect of exacerbation on plasma levels of tissue factor in patients with COPD. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Meade TW (1999). Haemostatic function, arterial disease and the prevention of arterial thrombosis. nameOfConference


    QMRO: qmroHref
  • (1999). Preface. nameOfConference


    QMRO: qmroHref
  • Kennon S, Suliman A, MacCallum PK et al. (1998). Clinical characteristics determining the mode of presentation in patients with acute coronary syndromes. nameOfConference


    QMRO: qmroHref
  • Seemungal T, MacCallum P, Wedzicha JA (1998). Plasma fibrinogen is a marker of COPD exacerbation. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Poller L, Shiach C, MacCallum P et al. (1998). Multicentre randomised study of computerised anticoagulant dosage. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Cooper JA, Meade TW et al. (1996). P26. Comparison of associations of prothrombin fragment F1.2 and D-dimer in a healthy population. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Cooper JA, Miller GJ et al. (1995). Determinants of the dilute clot lysis time (DCLT) in a healthy general practice-based population—the Harefield Study. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Rohatiner AZS, Davis CL et al. (1995). Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukemia in older patients. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Meade TW, Cooper JA et al. (1995). Clotting factor VIII and risk of deep-vein thrombosis. nameOfConference


    QMRO: qmroHref
  • Meade TW, Howarth DJ, Cooper J et al. (1994). Fibrinolytic activity and arterial disease. nameOfConference


    QMRO: qmroHref
  • Rohatiner AZ, Johnson PW, Price CG et al. (1994). Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma.. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Davis CL, Rohatiner AZ et al. (1993). Mitoxantrone and cytosine arabinoside as treatment for acute myelogenous leukemia (AML) at first recurrence.. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Lillington DM, MacCallum PK, Lister TA et al. (1993). Translocation t(6;9)(p23;q34) in acute myeloid leukemia without myelodysplasia or basophilia: two cases and a review of the literature.. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Bassan R, Battista R, Rohatiner AZ et al. (1992). Treatment of adult acute lymphoblastic leukaemia (ALL) over a 16 year period.. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Gibbons B, MacCallum P, Watts E et al. (1991). Near haploid acute lymphoblastic leukemia: seven new cases and a review of the literature.. nameOfConference

    DOI: doi

    QMRO: qmroHref
  • Poller L, MacCallum PK, Thomson JM et al. (1990). Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study.. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Newbould MJ, Sambrook PS et al. (1988). Extramedullary haemopoietic tumours complicating polycythaemia vera.. nameOfConference


    QMRO: qmroHref
  • MacCallum PK, Freemont AJ, Geary CG et al. (1988). A case of IgD myeloma presenting as diffuse osteosclerosis.. nameOfConference


    QMRO: qmroHref
  • Smith SR, Auger MJ, Maccallum PK et al. (1987). HYPOTHYROIDISM AND VON WILLEBRAND'S DISEASE. nameOfConference


    QMRO: qmroHref
  • Gozzard DI, MacCallum PK, Love EM (1986). Management of infection in the neutropenic patient. nameOfConference


    QMRO: qmroHref

Supervision

MD(Res) Ruchika Kohli, British Society for Haematology Early Stage Grant, Evaluation of pharmacological thromboprophylaxis in renal transplantation: evidence, current practice, and haemostatic changes.

Back to top